Dublin, May 15, 2024 (GLOBE NEWSWIRE) -- The "Global Microarray Analysis Market - A Global and Regional Analysis: Focus on Product, Type, Application, End User, Region, Country Level Analysis and ...

ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray ...

The expectation that microarray technology will play a large role in shaping the future of pharmaceutical development and diagnostics has increased due to new products and applications. Microarrays ...

Gentel® Biosciences has announced that it has obtained an exclusive license to novel technology for manufacturing highly-reproducible nitrocellulose protein microarray slides. The technology, ...

The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...

DUBLIN--(BUSINESS WIRE)--The "China Microarray Market Size, Share, Forecast, & Trend Analysis by Product, Application, End User- Forecast to 2031" report has been added to ResearchAndMarkets.com's ...

EPperPRINT, a global leader in peptide microarray technology, celebrates its 15th anniversary with the launch of its next-generation peptide microarray platform: cLIFT, short for combinatorial ...

The MarketWatch News Department was not involved in the creation of this content. -- Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch" technology and utilizes ...

"[People] had been developing Arabidopsis microarrays for a number of years, and these were some of the first papers that published high-quality data with real biological conclusions," says Chris Town ...

Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch” technology and utilizes Micron's first-in-class dissolvable microarray technology Research builds on Emory's ...